update deskIsrael News

Israeli companies, investors meet in New York for first-ever ‘Cannabis Investment Symposium’

“Israel is a center of excellence for medical cannabis—it’s like Switzerland is for banking, the place you go to find the real experts,” says Stephen Konigsberg of Tikun Olam USA.

Israel has become the leader in cannabis research and innovation, using data to show the efficacy of cannabinoids (the active components of cannabis) in treating a range of health conditions, such as epilepsy and autism. Photo by Kobi Gideon/Flash90.
Israel has become the leader in cannabis research and innovation, using data to show the efficacy of cannabinoids (the active components of cannabis) in treating a range of health conditions, such as epilepsy and autism. Photo by Kobi Gideon/Flash90.

About 150 entrepreneurs and investors gathered in New York City last week to learn about Israel’s innovative medical cannabis industry at the first-ever “Cannabis Investment Symposium.”

“We are thrilled to introduce the best Israeli cannabis entrepreneurs and their companies to New York’s vibrant investment community and share our deep connections and insights,” said iCAN: Israel-Cannabis CEO Saul Kaye at the symposium.

“Israel is attracting investment from the world’s largest cannabis companies as well as from emerging markets in Latin America, Africa and Asia,” he said.

The international market for Israeli cannabis technology is “rapidly expanding,” said Kaye, urging the American financial community, which has previously invested in cannabis “state by state” to expand their investments to meet the global opportunity.

According to an iCan press release, cannabis is the fastest growing market in the world, with the medical cannabis industry alone expected to generate $148 billion globally by 2026 “as countries throughout the world continue to legalize its use and demand continues to grow.”

Since Israel legalized medical cannabis in the early 1990s, the Jewish state has become the leader in cannabis research and innovation, using objective measures to show the efficacy of cannabinoids (the active components of cannabis) in treating a range of health conditions such as epilepsy and autism.

At the symposium, Israeli Consul General Dani Dayan exclaimed, “If you want to understand how important and strategic this industry is, the only two living former prime ministers of Israel, Ehud Barak and Ehud Olmert, are both in the legal cannabis industry.”

Tal Ohana, mayor of Israel’s southern city of Yeruham, urged participants to visit Israel and invest, promising, “We will support you and the Israeli government will do much more including granting subsidies for land, for highly skilled labor and taxes.”

According to Stephen Konigsberg of Tikun Olam USA, “Israel is a center of excellence for medical cannabis—it’s like Switzerland is for banking, the place you go to find the real experts.”

iCAN Connect sponsors included the New York Israel Chamber of Commerce, America Israel Cannabis Association, the Israeli Economic Mission in New York, Tress capital and Vanguard Scientific Systems.

You have read 3 articles this month.
Register to receive full access to JNS.

Just before you scroll on...

Israel is at war. JNS is combating the stream of misinformation on Israel with real, honest and factual reporting. In order to deliver this in-depth, unbiased coverage of Israel and the Jewish world, we rely on readers like you. The support you provide allows our journalists to deliver the truth, free from bias and hidden agendas. Can we count on your support? Every contribution, big or small, helps JNS.org remain a trusted source of news you can rely on.

Become a part of our mission by donating today
Topics
Comments
Thank you. You are a loyal JNS Reader.
You have read more than 10 articles this month.
Please register for full access to continue reading and post comments.
Never miss a thing
Get the best stories faster with JNS breaking news updates